A bill for an act relating to prior authorization requirements for the treatment of cancer.

HF 217 prevents health insurance companies and utilization review organizations in Iowa from requiring prior approval for cancer treatments recommended by a patient's doctor using National Comprehensive Cancer Network (NCCN) protocols. This directly affects cancer patients and their healthcare providers by removing a common administrative barrier to timely care. The bill’s key provision mandates that insurers must cover these NCCN-recommended treatments without prior authorization. It changes the policy by requiring insurers to follow established clinical guidelines for cancer care, rather than imposing separate approval steps.